University of Alberta
Faculty of Medicine – Oncology – Non-Bud
Dianne and Irving Kipnes Chair in Lymphatic Disorders
Competition No. – A105340857
Closing Date – Will remain open until filled.
The Department of Oncology in the Faculty of Medicine & Dentistry at the University of Alberta in conjunction with the Cancer Research Institute of Northern Alberta (CRINA) invite applications for a tenure-track appointment for an academic scientist /clinician-scientist at the Associate Professor or Professor level to direct a program in lymphatic disorders research of international renown. The selected candidate will hold the Dianne and Irving Kipnes Chair in Lymphatic Disorders (the only dedicated lymphatic disorders research chair in Canada) and will be supported by a substantial establishment grant to rapidly build a world-leading team in this research area.
The successful candidate will have the following qualifications:
• An MD, PhD or MD/PhD is required
• Possess a strong reputation and proven leadership in the field of Lymphatic Disorders
• Expertise and accomplishments directly related to Lymphatic Disorders
• Success in applying for grant funding with the intention to further enhance the research and education program
• Proven success in attracting and mentoring graduate students and post-doctoral fellows
• Visionary leader with excellent interpersonal skills and ability to build relationship that bring a variety of stakeholders and multi-disciplined researchers together
• Have effective links with community groups that have an interest in Lymphatic Disorders research with the goal to work collaboratively and actively link research with practice.
The Dianne and Irving Kipnes Chair is a $5M endowed chair that will be accompanied by a $2M establishment grant designed to support a vibrant research team. The selected candidate shall provide visionary leadership in basic and clinical science, with a focus on developing and maintaining a world-class program in lymphatic disorders research. The Chair in Lymphatic Disorders represents an institutional strategic direction aimed at international leadership in research designed to dramatically improve the treatment, diagnosis and prevention of both cancer-related and non-cancer-related lymphedema as well as related processes, such as the lymphatic dissemination of cancer, which impact patient outcomes. Studies already underway via the Alberta Lymphedema Network (ALNET) include the use of metabolomics and proteomics to search for biomarkers that can aid in the diagnosis, prognosis and identification of risk factors for lymphedema and the testing of new imaging tools to aid in early treatment. The Kipnes Chair will expand and reshape already established programming in novel directions.
The inaugural chair holder’s area of expertise and chosen area of focus could include engineering new lymphatic vessels; pioneering new techniques to remove tumours without damaging the lymphatic system; repairing lymph vessels; targeting genetic mechanisms of lymphedema; developing novel treatment regimens; developing novel imaging methods or biomarkers; expanding existing therapies and approaches so that they are more effective; and creating educational and/or knowledge transfer programs for both patients and health care providers. Accordingly, academic affiliations could be in clinical disciplines including Oncology, Surgery, Cardiology, Dermatology, Pathology/Laboratory Medicine, or Radiology and Diagnostic Imaging or in biomedical sciences including Medical Genetics, Biochemistry, Cell Biology, Immunology, Pharmacology or Physiology.
The lymphatics research program, headed by the Dianne and Irving Kipnes Chair, will be a flagship program at CRINA. CRINA brings expert teams of cancer scientists and clinicians together in one of the largest comprehensive cancer research institutes in Canada. Those associated with this multidisciplinary institute investigate cancer biology, novel therapies and biomarkers, as well as prevention, lifestyle and survivorship after diagnosis. Team members work together on solutions to patient needs and translate research discoveries into treatments more rapidly and comprehensively than they could independently. Through CRINA, the Kipnes Chair will be able to translate breakthroughs into clinical trials, building the body of knowledge that researchers will use to find solutions in the future. In addition, the Kipnes chair will benefit from the university’s participation in the Northern Alberta Clinical Trials + Research Centre (NACTRC), a joint venture between the University of Alberta and Alberta Health Services (AHS). NACTRC serves investigators like the Kipnes Chair by increasing studies and streamlining clinical trials processes.
The Faculty of Medicine & Dentistry has been internationally recognized among the world’s top medical schools and has a vibrant, world-class community of health researchers. The University of Alberta is one of Canada’s top teaching and research universities, with an international reputation for excellence across the humanities, sciences, creative arts, business, engineering, and health sciences. Home to 39,000 students and 15,000 faculty and staff, the university has an annual budget of $1.8 billion and attracts more than $480 million in sponsored research revenue. It offers close to 400 rigorous undergraduate, graduate, and professional programs in 18 faculties on five campuses—including one rural and one francophone campus. The university has more than 260,000 alumni worldwide. The university and its people remain dedicated to the promise made in 1908 by founding president Henry Marshall Tory that knowledge shall be used for “uplifting the whole people.”
Interested individuals should submit: a cover letter and curriculum vitae, including the names and contact information of three referees; a statement of their research interests and a description of a proposed 5-year research plan for the Chair.
Please direct all inquiries to:
Dr. David Eisenstat
Professor and Chair, Department of Oncology
Faculty of Medicine & Dentistry
University of Alberta
To assist the University in complying with mandatory reporting requirements of the Immigration and Refugee Protection Act (R203 (3) (e)), applicants will be asked to include the first digit of their Canadian Social Insurance Number on this form. If you do not have Canadian Social Insurance Number please indicate this in your application.
The University of Alberta and Alberta Health Services hire on the basis of merit. We are committed to the principle of equity in employment. We welcome diversity and encourage applications from all qualified women and men, including persons with disabilities, members of visible minorities and Aboriginal persons.
Interested applicants may apply to: https://www.careers.ualberta.ca/Competition/A105340857/
The University of Alberta is committed to an equitable, diverse, and inclusive workforce. We welcome applications from all qualified persons. We encourage women; First Nations, Métis and Inuit persons; members of visible minority groups; persons with disabilities; persons of any sexual orientation or gender identity and expression; and all those who may contribute to the further diversification of ideas and the University to apply.